T3DB: the toxic exposome database

The exposome is defined as the totality of all human environmental exposures from conception to death. It is often regarded as the complement to the genome, with the interaction between the exposome and the genome ultimately determining one's phenotype. The ‘toxic exposome’ is the complete collection of chronically or acutely toxic compounds to which humans can be exposed. Considerable interest in defining the toxic exposome has been spurred on by the realization that most human injuries, deaths and diseases are directly or indirectly caused by toxic substances found in the air, water, food, home or workplace. The Toxin-Toxin-Target Database (T3DB - www.t3db.ca) is a resource that was specifically designed to capture information about the toxic exposome. Originally released in 2010, the first version of T3DB contained data on nearly 2900 common toxic substances along with detailed information on their chemical properties, descriptions, targets, toxic effects, toxicity thresholds, sequences (for both targets and toxins), mechanisms and references. To more closely align itself with the needs of epidemiologists, toxicologists and exposome scientists, the latest release of T3DB has been substantially upgraded to include many more compounds (>3600), targets (>2000) and gene expression datasets (>15 000 genes). It now includes extensive data on ‘normal’ toxic compound concentrations in human biofluids as well as detailed chemical taxonomies, informative chemical ontologies and a large number of referential NMR, MS/MS and GC-MS spectra. This manuscript describes the most recent update to the T3DB, which was previously featured in the 2010 NAR Database Issue.

[1]  David M. Reif,et al.  Profiling 976 ToxCast Chemicals across 331 Enzymatic and Receptor Signaling Assays , 2013, Chemical research in toxicology.

[2]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..

[3]  Miron Livny,et al.  BioMagResBank , 2007, Nucleic Acids Res..

[4]  Christoph Steinbeck,et al.  The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013 , 2012, Nucleic Acids Res..

[5]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[6]  David S. Wishart,et al.  SMPDB: The Small Molecule Pathway Database , 2009, Nucleic Acids Res..

[7]  David S. Wishart,et al.  T3DB: a comprehensively annotated database of common toxins and their targets , 2009, Nucleic Acids Res..

[8]  Kamyar Kalantar-Zadeh,et al.  Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease , 2013, American Journal of Nephrology.

[9]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[10]  Mick Ballesteros,et al.  161 An evaluation of CDC’s web-based injury statistics query and reporting system (WISQARS) , 2016 .

[11]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[12]  Li Hui Chen,et al.  Drug poisoning deaths in the United States, 1980-2008. , 2011, NCHS data brief.

[13]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[14]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[15]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[16]  Henrik Druid,et al.  Incidence of fatal adverse drug reactions: a population based study. , 2008, British journal of clinical pharmacology.

[17]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[18]  Tomoyoshi Soga,et al.  Oncometabolites: linking altered metabolism with cancer. , 2013, The Journal of clinical investigation.

[19]  Paolo Vineis,et al.  The Blood Exposome and Its Role in Discovering Causes of Disease , 2014, Environmental health perspectives.

[20]  A. Grizzle,et al.  Drug-related morbidity and mortality: updating the cost-of-illness model. , 2001, Journal of the American Pharmaceutical Association.

[21]  Z. Massy,et al.  Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. , 2013, Journal of the American Society of Nephrology : JASN.